Breaking: Robust Expansion in the US Pharmaceutical Contract Manufacturing Market
The US Pharmaceutical Contract Manufacturing Market is on a noteworthy trajectory, projected to grow significantly, reaching an estimated market size of USD 86.16 billion by 2035. This evolution is underscored by a compound annual growth rate (CAGR) of 4.56%, indicative of increasing reliance on external manufacturing capabilities among pharmaceutical companies. As firms look to capitalize on...
0 Yorumlar 0 hisse senetleri 758 Views 0 önizleme
social art-inpa https://social.art-inpa.com